Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

about

Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

P2860

Q47350013-46668728-C3C8-414B-ABC6-16E6C13FA3F3

P2860

Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

Item

http://www.wikidata.org/entity/Q35905805

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@ast

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@en

type

Item

label

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@ast

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@en

prefLabel

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@ast

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@en

P1476

Modulation of influenza vaccin ...... tor receptor kinase inhibitor.

@en

P2093

Bishu Sapkota

http://www.w3.org/2001/XMLSchema#string

Brian P Pollack

http://www.w3.org/2001/XMLSchema#string

E Stein Esser

http://www.w3.org/2001/XMLSchema#string

Ioanna Skountzou

http://www.w3.org/2001/XMLSchema#string

Joanna A Pulit-Penaloza

http://www.w3.org/2001/XMLSchema#string

Richard W Compans

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation

Adjuvants for pandemic influenza vaccines.

Transdermal influenza immunization with vaccine-coated microneedle arrays.

A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches.

The value of vaccination: a global perspective.

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

Local response to microneedle-based influenza immunization in the skin.

P2888

srep12321

P304

12321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP12321

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281817964

http://www.w3.org/2001/XMLSchema#string

P698

26227481

http://www.w3.org/2001/XMLSchema#string

P932

4521188

http://www.w3.org/2001/XMLSchema#string

Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

about

P2860

P2860

Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P698

P932